Conference review: scientific session of the American College of Cardiology 1996.
Several truly "landmark' studies were presented during the 45th Annual Scientific Session of the American College of Cardiology (ACC). This report reviews studies of markers of atherosclerosis and some of the trials in endothelial dysfunction (TREND), lipid lowering (CARE), coronary angioplasty and unstable angina (EPILOG, CAPTURE, RESTORE), acute myocardial infarction (HERO, GUSTO 11b), post-myocardial infarction (EMIAT, CAMIAT), and heart failure (DIG trial).
Purcell
H
H
Royal Brompton Hospital, London.
D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D015415:Biomarkers; D002309:Cardiology; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004077:Digoxin / Q000627:therapeutic use; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D017035:Pravastatin / Q000627:therapeutic use; D012955:Societies, Medical
D000889:Anti-Arrhythmia Agents; D000924:Anticholesteremic Agents; D000925:Anticoagulants; D015415:Biomarkers; D004077:Digoxin; D017035:Pravastatin; D000638:Amiodarone